Ultrasonic Mist Inhaler Frequency Tuning for Fine Aerosol Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional mist inhaler devices, particularly ultrasonic nebulizers, are ineffective for viscous suspensions, tend to heat medications, and produce large droplets that deposit in the oropharyngeal region, leading to inefficiencies and potential damage from second-hand smoke effects.

Innovation Solution

An ultrasonic mist inhaler device utilizing a frequency range of 2.8MHz to 3.2MHz and a capillary element made of bamboo fibers to produce droplets of 0.25 to 0.5 microns without heating, enhancing therapeutic delivery and reducing power consumption.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Temperature

If conventional ultrasonic nebulizers are used, then aerosol generation is achieved, but the medication is heated and molecules are destroyed

Engineering Contradiction:
Improvemedication temperatureVSAvoidmolecule integrity
Core Design Contradiction:
TemperatureVSReliability

Solution Approach 1:

The patent employs ultrasonic vibration at a specific frequency range (2.8MHz to 3.2MHz) to atomize the liquid medication without converting it to vapor through heating. The mechanical vibration directly breaks the liquid into fine droplets, eliminating the thermal damage that occurs in conventional heating-based inhalers while maintaining effective aerosol generation for pulmonary delivery

Inventive Principle:
Principle #18Mechanical vibration

2Productivity

If conventional ultrasonic nebulizers operate at high intensity, then aerosol production increases, but power consumption increases

Engineering Contradiction:
Improveaerosol production efficiencyVSAvoidpower consumption
Core Design Contradiction:
ProductivityVSUse of energy by moving object

Solution Approach 1:

The patent optimizes the ultrasonic frequency parameter to a specific range (2.8MHz to 3.2MHz) that achieves efficient aerosol generation at lower power levels. This parameter optimization allows the device to produce sufficient therapeutic aerosol concentration without requiring high-intensity operation, thereby reducing power consumption while maintaining productivity

Inventive Principle:
Principle #35Parameter changes

3Device complexity

If jet nebulizers are used, then device simplicity is maintained, but large droplets are produced that deposit in the oropharyngeal region

Engineering Contradiction:
Improvedevice structureVSAvoiddroplet size control
Core Design Contradiction:
Device complexityVSManufacturing precision

Solution Approach 1:

The patent uses ultrasonic vibration to achieve precise control over droplet size, producing fine aerosol particles that bypass oropharyngeal deposition and reach the lungs effectively. This vibration-based atomization method provides superior droplet size control compared to jet nebulizers while maintaining relatively simple device structure

Inventive Principle:
Principle #18Mechanical vibration

Solution Approach 2:

By controlling the ultrasonic frequency within the specific range of 2.8MHz to 3.2MHz, the patent achieves precise droplet size control that optimizes pulmonary delivery. This parameter control ensures droplets are small enough to reach the lungs but not so small as to be exhaled, resolving the deposition issue without complex device architecture

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device achieves higher efficiency and reduced power consumption while effectively delivering therapeutic aerosols directly to the lungs, minimizing oropharyngeal deposition and second-hand smoke risks.

Implementation Method 1

During the low-pressure cycle, high-intensity ultrasonic waves create small vacuum bubbles or voids in the liquid. When the bubbles attain a volume at which they can no longer absorb energy, they collapse violently during a high-pressure cycle. This phenomenon is termed cavitation.

Methodology Applied
Scientific EffectCavitation: Cavitation

Implementation Method 2

ultrasonic nebulizers use piezoelectric crystals that vibrate at frequencies, ranging between 1 MHz and 1.7 MHz, transmitting the vibratory energy to the liquid converting it to aerosol

Methodology Applied
Scientific EffectUltrasonic vibration: Ultrasonic Vibration

Implementation Method 3

a capillary element made of bamboo fibers to produce droplets of 0.25 to 0.5 microns

Methodology Applied
Scientific EffectCapillary action: Capillary Action

Data Source

PatentEP4338850B1Mist inhaler devices
Publication Date: 2025.07.09 SHAHEEN INNOVATIONS HLDG LTD
  • EP4338850B1 patent drawingFigure 1
  • EP4338850B1 patent drawingFigure 2
  • EP4338850B1 patent drawingFigure 3

AI summary

A mist inhaler device (200) for generating a mist comprising a therapeutic for inhalation by a user. The device comprises a mist generator device (201) and a driver device (202). The driver device (202) is configured to drive the mist generator device (201) at an optimum frequency to maximise the efficiency of mist generation by the mist generator device (201).